# A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects

> **NCT01406132** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 6 (actual)

## Conditions studied

- Healthy Subjects
- Pharmacokinetics of ASP015K

## Interventions

- **DRUG:** ASP015K

## Key facts

- **NCT ID:** NCT01406132
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01406132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01406132, "A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01406132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*